Price Hikes for Hemp Licenses Could be Coming in Washington State  Written by Orion Inskip, Attorney at Gleam Law with focus on CBD Law. Hemp, once a staple of American industry, is slowly taking hold as a cash crop. The aftermath of 1998’s legalization of the importation of hemp has shown that there is a…

CBD Status Quo, in Limbo Despite the baited anticipation for announcements from the DEA and Congress this week, the announcements from Congress and the DEA today change nothing about CBD’s legal status in the eyes of the federal government.   FDA Approved Epidiolex…Now What? Once the FDA approved Epidiolex, a medicine derived from CBD, as…

Ohio Takes a Swing at CBD Written by Orion Inskip, Attorney at Gleam Law that specializes in CBD. Yet another state takes a hardline stance against CBD sold outside the regulated medical cannabis market. With the Ohio Pharmacy Board’s recent “Clarification on Cannabidiol (CBD) Oil”, Ohio has joined states like California and Michigan in ignoring…

California Department of Public Health Prohibits CBD in Food Products By Orion Inskip, Attorney at Gleam Law PLLC According to a recent FAQ released by the California Department of Public Health’s Food & Drug Branch (CDPH-FDB), CBD is prohibited from use in any food product sold outside of the legal cannabis industry in the state….

BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC.  The Food and Drug Administration (FDA) has approved Epidiolex, an epilepsy medicine derived from marijuana. The drug’s active ingredient is a non-psychoactive cannabinoid known as cannabidiol (CBD) and is the first marijuana-based medication approved by the FDA. This…

Is CBD Legal?: The Complicated Legal World of Hemp & Cannabis CBD Written by Orion Inskip, Attorney at Gleam Law, PLLC. Cannabis laws are rapidly evolving across the world. This has been no less true when it comes to cannabidiol, more popularly known as CBD. CBD is a naturally occurring compound found in cannabis that…

What You Need to Know About The Latest Bipartisan Federal Cannabis Bill, The STATES Act Written by Ammon J. Ford, Attorney at Gleam Law, PLLC.  In the wake of U.S. Attorney General Jeff Sessions’ anti-marijuana rhetoric, a bipartisan bill has been proposed to protect states’ legal cannabis industries. Senators Elizabeth Warren (D-MA) and Cory Gardner…

The FDA recently sent warning letters two four CBD companies. Written by Orion Inskip, Attorney at Gleam Law, PLLC.  The Federal Drug Administration (FDA) regulates medicine throughout the United States.  Their power flows from the  Federal Food, Drug, and Cosmetic Act (FDCA), enacted by Congress in 1938. Under the FDCA companies cannot advertise that a drug will…

Not for Kids Warning Symbol Not For Kids Warning Symbol Adopted in Washington – The Washington State Liquor and Cannabis Board adopted the long awaited “not for kids” warning label and will require it to be on all edible cannabis products sold in the state, effective February 14, 2017. What do the rules require? The…

Washington Medical Marijuana Patients Need Legal Protection Washington medical cannabis patients face obstacles to access. The Cannabis Patient Protection Act (CPPA) (a.k.a. SB 5052) will take full effect on July 1st. The new law fixed a whole host of problems with the initial rules adopted after I-502, such as restructuring the taxation of cannabis, strengthening consumer protections,…